Shows
Rio Bravo qWeekEpisode 188: RSV Management and PreventionEpisode 188: RSV Management and PreventionDr. Sandhu and future Dr. Mohamed summarize the management of RSV and describe how to prevent it with chemoprophylaxis and vaccines. Dr Arreaza adds some comments about RSV vaccines.Written by Abdolhakim Mohamed, MSIV, Ross University School of Medicine. Comments by Ranbir Sandhu, MD, and Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare...2025-04-1115 min
Dr. Howard Smith ReportsA Longer-Lasting RSV VaccineVidcast: https://www.instagram.com/drhowardsmithreports/reel/DH9MacqsZKC/A novel, bivalent RSV vaccine provides lasting protection against respiratory syncytial viral disease over two rather than only one season. This the result of a phase 3 so-called RENOIR trial that tested 36,862 participants 60 to over 80 years of age at 241 sites in 7 countries. Helmed by University of Rochester infectious disease researchers, it was just reported in the Clinical Infectious Diseases journal.The vaccine, developed by Pfizer, contains both RSV-A and RSV-B antigens. Tested against a placebo, the vaccine provided 88.9% prot...2025-04-0201 min
Radio Haanji PodcastRSV Vaccine for Pregnant Women – How Can a Newborn Be Protected?ਗਰਭਵਤੀ ਔਰਤਾਂ ਲਈ RSV (Respiratory Syncytial Virus) ਟੀਕਾ ਨਵਜੰਮੇ ਬੱਚਿਆਂ ਦੀ ਸਿਹਤ ਦੀ ਰੱਖਿਆ ਲਈ ਮਹੱਤਵਪੂਰਨ ਮੰਨਿਆ ਜਾਂਦਾ ਹੈ। Abrysvo RSV ਟੀਕੇ ਦੀ ਇਕ ਮਾਤਰ ਖੁਰਾਕ 28 ਤੋਂ 36 ਹਫ਼ਤੇ ਦੀ ਗਰਭਾਵਸਥਾ ਵਿੱਚ ਲਗਵਾਉਣ ਦੀ ਸਿਫਾਰਸ਼ ਕੀਤੀ ਜਾਂਦੀ ਹੈ। ਇਹ RSV ਟੀਕਾ ਮਾਂ ਦੇ ਸ਼ਰੀਰ ਰਾਹੀਂ ਬੱਚੇ ਨੂੰ ਪਰੋਟੈਕਟ ਕਰਨ ਵਿੱਚ ਮਦਦ ਕਰਦਾ ਹੈ।
Abrysvo RSV ਟੀਕੇ ਦੀ ਮੰਜ਼ੂਰੀ ਗਰਭਵਤੀ ਔਰਤਾਂ ਲਈ ਦਿੱਤੀ ਗਈ ਹੈ, ਜਦਕਿ Arexvy ਟੀਕਾ ਗਰਭਵਤੀ ਔਰਤਾਂ ਲਈ ਨਹੀਂ। RSV ਇਨਫੈਕਸ਼ਨ ਜ਼ਿਆਦਾਤਰ ਨਵਜੰਮੇ ਬੱਚਿਆਂ ਵਿੱਚ bronchiolitis ਵਰਗੀਆਂ ਗੰਭੀਰ ਰੋਗਾਂ ਨੂੰ ਜਨਮ ਦਿੰਦਾ ਹੈ, ਜਿਸ ਕਰਕੇ ਬੱਚਿਆਂ ਨੂੰ ਹਸਪਤਾਲ ਵਿੱਚ ਦਾਖਲ ਕਰਨਾ ਪੈ ਸਕਦਾ ਹੈ। RSV ਟੀਕੇ ਦੇ ਜ਼ਰੀਏ 6 ਮਹੀਨੇ ਤਕ ਦੇ ਬੱਚਿਆਂ ਵਿੱਚ ਇਸ ਦੀ ਗੰਭੀਰਤਾ 70% ਤਕ ਘਟਾਈ ਜਾ ਸਕਦੀ ਹੈ।
RSV ਟੀਕਾ ਜਿਵੇਂ ਕਿ Abrysvo, DTaP, Influenza, ਅਤੇ COVID-19 vaccines ਦੇ ਨਾਲ ਵੀ ਲਗਾਇਆ ਜਾ ਸਕਦਾ ਹੈ। ਜੇਕਰ ਗਰਭਵਤੀ ਔਰਤ 36 ਹਫ਼ਤੇ ਤੱਕ RSV ਟੀਕਾ ਨਹੀਂ ਲਗਵਾ ਸਕਦੀ, ਤਾਂ ਜੰਮਣ ਤੋਂ ਬਾਅਦ nirsevimab (RSV-specific monoclonal antibody) ਨਾਲ ਬੱਚੇ ਨੂੰ ਪੂਰੀ ਸੁਰੱਖਿਆ ਦਿੱਤੀ ਜਾ ਸਕਦੀ ਹੈ।
Source- https://immunisationhandbook.health.gov.au/recommendations/pregnant-women-are-recommended-to-receive-an-rsv-vaccine-during-pregnancy-to-protect-the-infant
2025-03-1506 min
Talking All Things CardiopulmEpisode 96: RSV is it Droplet? or Contact? or Both?As the winter season comes to an end, we review 1 of the 4 major viruses that has been rampant this year. Though RSV is officially on the decline, it is still very present in our communities and hospitals. Join us as we discuss virus transmission and possible precautions, that you may say in your setting. Is it Droplet or is it Contact? That seems to be a question these days and there seems to be some unclear writing on the wall. So let’s break it down. In this episode:Discuss pathophysiology of RSVTransmission of RSVCurren...2025-02-2630 min
The PedsDocTalk Podcast: Child Health, Development & Parenting—From a Pediatrician MomHelp Reduce Risk of Serious RSV Lung Infection for Your BabyDid you know while hospitalization is uncommon, respiratory syncytial virus (RSV) is the leading cause of hospitalization for babies under 1? RSV season is typically fall – spring but can vary by local areas and today I'm sharing about a preventative antibody which can help protect against severe RSV lung infections. I'm joined by Shawn Johnson East and Dr. Natalie Barnett, Vice President of Clinical Research at Nanit, to discuss the importance of RSV protection for babies. They share personal experiences, including Shawn's family's journey with RSV, and offer expert insights on how parents can help protect their little ones during RS...2024-12-1829 min
Pharmacy FriendsRSV: 'Tis the season for preventionDr. Scott Roberts, an infectious disease expert from Yale University, is back with us to share information about updated CDC guidelines for RSV vaccinations in a variety of populations. He also talks about how our nation’s health care systems seem to be much better equipped this RSV season. Finally, you’ll come away with a better understanding of what everyone can do to help prepare for this RSV season.
Pharmacy Friends Rewind: Last winter, we talked with Dr. Roberts about the new frontier of RSV vaccines. We chatted about access issues, along with RSV impact...2024-12-1725 min
A WonderCare PodcastRSV - Update - Is the Immunisation Working?!Understanding RSV and the Impact of NursivMab ImmunizationIn this week's episode, Sheena discusses Respiratory Syncytial Virus (RSV) and provides an update on the current RSV season. She explains the effects of Nirsevimab, the new RSV immunisation introduced through a Pathfinder program for babies born between September 1st and February 28th. She also reads a letter she wrote to Dr. Colm Henry and Minister Stephen Donnelly, urging them to extend the immunization to more babies. She provides insights into how RSV affects different age groups, the success of the Pathfinder program, and encourages listeners to advocate...2024-12-1418 min
Your Checkup: What You Wish Your Doctor ExplainedRSV Prevention for Infants: Nirsevimab & Maternal VaccineSend us a message with this link, we would love to hear from you. Standard message rates may apply.Respiratory syncytial virus (RSV) is a common respiratory virus that can be dangerous for infants. This episode of Your Checkup provides essential information about RSV, exploring new prevention methods like the monoclonal antibody nirsevimab and the maternal RSV vaccine. We discuss how they work, who should consider them, and their safety profiles. Tune in to learn how to safeguard your baby from this potentially serious virus.TakeawaysRSV is a common respiratory virus...2024-11-1124 min
SMFM's Podcast SeriesMaternal RSV Vaccination 101In this episode of the SMFM Podcast, Dr. Marwan Ma’ayeh discusses maternal RSV vaccination with Dr. Sarah Boudova, an expert in infectious diseases and a third-year maternal-fetal medicine fellow. They dive into the Abrysvo vaccine and explain its importance for protecting newborns from RSV-related respiratory illnesses. Dr. Boudova provides essential insights into the vaccine's components, its unique role during pregnancy, timing considerations, and co-administration with other vaccines. They also touch on current recommendations from leading health organizations and outline practical advice for healthcare providers on storing and administering the vaccine. Listen to learn how maternal RSV vaccination can sa...2024-11-0421 min
The Oh Baybee! PodcastDo This To Protect Your Baby From RSVSend us a textEp 42:Welcome, mama! Today, we’re covering an essential topic to help you protect your newborn from RSV. RSV, or respiratory syncytial virus, can cause serious respiratory issues in infants. The good news? Breastfeeding can be a natural defense!In this episode, we cover:What RSV is: Understanding the virus and why it can pose a risk to babies, especially those under six months.How Breastfeeding Helps: Discover how breast milk’s immune-boosting properties, like antibodies and white blood cells, protect agai...2024-10-3105 min
The Medical Minute: Dr Anne and Dr MozThe Medical Minute - 2024 Episode 10 - Guardians of the Airways: RSV Immunisation UnveiledThis week, Dr Anne and Dr Moz discuss the RSV vaccine, covering immunisation for pregnant women and infants.
IMPORTANT LINKS:
Handbook on Maternal RSV Vaccination (Abrysvo):
https://immunisationhandbook.health.gov.au/recommendations/pregnant-women-are-recommended-to-receive-an-rsv-vaccine-during-pregnancy
Guide for which infants should receive the RSV jab (Beyfortus):
https://immunisationhandbook.health.gov.au/resources/figures/figure-flowchart-to-guide-which-infants-should-receive-nirsevimab-in-their-1st-rsv-season
Currently available information on the intended state-funded RSV infant immunisation program:
https://www.betterhealth.vic.gov.au/respiratory-syncytial-virus-rsv#2025-rsv-infant-immunisation-program
Follow The Medical Minute on Instagram:
https://www.instagram...2024-10-1823 min
A WonderCare PodcastAn Honest Guide to the new RSV Immunisation!Comprehensive Guide to the New RSV Immunisation for ParentsIn this detailed episode, I provide an in-depth exploration of the new RSV immunisation, focusing on its importance, safety, and effectiveness. The discussion covers the basics and risks of Respiratory Syncytial Virus (RSV), the introduction and benefits of the Nirsevimab vaccine, and potential side effects. The episode compares Nirsevimab with the older Palivizumab, highlighting its superior efficacy in reducing hospitalisations and ICU admissions. It also addresses eligibility guidelines, the vaccination process, accessibility through government programs, and specific advice for parents, especially those with infants born from September 1...2024-10-1829 min
VerifiedRxTake a Deep Breath: RSV Vaccinations InformationWe emerged from the COVID -19 pandemic in 2022 to headlines about unseasonably early spikes in respiratory syncytial virus and concerns and threats of a triple pandemic of CV19, influenza, and RSV. Fortunately, there’s been no triple pandemic, but what has emerged is multiple first-time vaccine approvals for RSV. Dr. John Schoen, Senior Manager of Drug Information at The Vizient Center for Phamacy Practice Excellence joins his colleague and Program Host Stacy Lauderdale, Associate Vice President of Evidence-Based Medicine to discuss the use of the RSV vaccines.
Guest speakers:
John Schoen, PharmD, BCPS
Senio...2024-10-0821 min
WSPID PodcastFighting RSV with Maternal ImmunizationIn this episode of the WSPID Podcast, hosts Dr. Alicia Chang and Dr. Linny Phuong come together to discuss RSV and the developments surrounding maternal immunization and therapeutics.
Featuring an insightful interview with A/Prof Flor Muñoz, MD, MSc, who is an Associate Professor of Pediatrics, Infectious Diseases, Molecular Virology, and Microbiology at Baylor College of Medicine, and Director of Transplant Infectious Diseases at Texas Children’s Hospital in Houston, Texas.
This conversation highlights the need for global collaboration and resources to implement these preventative measures.
This episode was recorded in May 2024, and...2024-09-1942 min
The Obs PodEpisode 175 RSV vaccineCurious about how the new RSV vaccine could protect your baby? Join me, Florence, as we uncover the latest addition to the UK’s maternal vaccination program. In this episode of the OBSpod, I break down everything you need to know about the respiratory syncytial virus (RSV) vaccine. Learn how this innovative recombinant vaccine works & why it's crucial for infants under a year old.Expectant mothers, healthcare professionals, and anyone interested in maternal and infant health will find this episode particularly enlightening. I'll guide you through the rationale behind the vaccine's introduction and its expected impact on bo...2024-08-1018 min
IDA-Sprechstunde"Neue RSV-Impfstoffe: 12 tote Babys!" - IDA-Sprechstunde #35 von 24.07.2024"Neue RSV-Impfstoffe: 12 tote Babys!" - IDA-SPRECHSTUNDE mit Dr. Gunter Frank & Dr. Kay Klapproth:
"Neue RSV-Impfstoffe: 12 tote Babys!" vom 24.7.24
Themen:
Es gibt neue Impfstoffe gegen RSV, die nun allen Babys und Menschen über 60 Jahren verabreicht werden sollen.
Impfung für alle: Die STIKO empfiehlt nun eine RSV-Impfung für alle Neugeborenen. Dabei ist das Risiko durch RSV-Infektionen sehr ungleich verteilt, und die Wirksamkeit sowie die Sicherheit der neuen Impfstoffe sind durchaus fraglich.
Neuer mRNA-Impfstoff: Auch gegen RSV-Infektionen gibt es jetzt einen genbasierten Impfstoff. Moderna nutzt die gleiche Technologie wie für ihren...2024-07-2443 min
Dr. Chapa’s Clinical Pearls.New Data (July 8, 2024) for Maternal RSV VaccineRSV season is just around the corner (Fall and Winter months). Newborns are 16x more likely to be hospitalized with serious RSV lung infection than the flu. On August 21, 2023, the FDA approved the first RSV vaccine, Abrysvo, for use in pregnant individuals to protect newborns and infants against severe RSV disease in the first 6 months after birth. The FDA approved the vaccine to be administered between 32 and 36 weeks and 6 days of gestation. Then, on September 22, 2023, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to recommend a single dose of maternal RSV vaccination for pregnant people at 32 through 36 we...2024-07-0939 min
Impfen mit Sinn und Verstand#37 RSV-Immunisierung: 200 Mio EUR für 1% RisikoreduktionEine veränderte STIKO Empfehlung
“Buy“-fortus (Beyfortus®): ca. 200 Mio. Euro jährlich für ca. 1% absolute Risikoreduktion“ - Eine passive Immunisierung, die Sanofi und Astra Zeneca aktiv nützt.
Thema: Die neueste Stiko-Empfehlung zur Prophylaxe gegen RSV-Infektionen für alle Neugeborenen und Säuglinge.
In dieser Episode geht es also um die neue STIKO-Empfehlung zum Thema RSV - ein Update zur Episode 27 unseres Podcasts.
Im Einzelnen geht es um Fragen wie diese:
Warum passt die STIKO die Empfehlung für den RSV an?
Auf welcher wissenschaftlichen Grundlage fußt diese Empfehl...2024-07-0528 min
A WonderCare PodcastDr Suzanne Crowe - Why the RSV Immunisation Programme for this Winter is not enoughDr. Suzanne Crowe, a pediatric intensivist, discusses her role in intensive care medicine and the impact of respiratory syncytial virus (RSV) on the health system. She emphasizes the need for vaccinating babies against RSV how crucial it is to expand the planned programme for this Winter. Dr. Crowe highlights the trauma that babies and their families experience when a baby is hospitalized with RSV and the strain it puts on healthcare resources. She calls for a more holistic approach to healthcare and the prioritization of children's health.Takeaways2024-07-0331 min
'ne Dosis Wissen | Der Medizin-Podcast für Menschen im GesundheitswesenRSV-Schutz für Säuglinge: Antikörper oder Impfung der Mutter?
Eine RSV-Infektion kann für Neugeborene gefährlich werden. Eine RSV-Impfung von schwangeren Frauen schützt den Nachwuchs laut einem neuen Cochrane-Review gut vor Krankenhausaufenthalten im Zuge einer RSV-Infektion. In ihren neuen Empfehlungen spricht sich die STIKO jedoch nicht für eine solche Impfung aus. Sie setzt stattdessen auf eine passive Immunisierung mit einem Antikörper. Dr. Laura Weisenburger, Ärztin und wissenschaftliche Redakteurin bei der Apotheken Umschau, spricht über beide Ansätze.
Stand: 3. Juli 2024
Quellen und nützliche Links
Aktueller Cochrane-Review zur RSV-Impfung von schwangeren Frauen (engl.)
STIKO-Empfehlung zur RSV-Prophylaxe bei Säuglinge...2024-07-0312 min
Medscape InDiscussion: Respiratory Syncytial Virus in AdultsWhen RSV Hits Home: Community Care in Rural West VirginiaJoin Drs Forest Arnold and Brittanie West as they discuss their personal experience preventing and managing RSV in adults in their Appalachian communities. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/998284. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview RSV in Rural Communities: Lessons From Appalachia https://www.medscape.com/viewarticle/985982 CDC RSV Surveillance and Research...2024-06-0421 min
CCO Infectious Disease PodcastUnderstanding Risk Factors for Severe RSV DiseaseIn this episode, Angela Branche, MD, FIDSA, explores the burden of RSV disease in older adults, including:RSV seasonality and disease burdenSymptoms and complications of RSV infectionOlder age as a key risk factor for severe RSV disease and complications (eg, pneumonia, hospitalization)Comorbidities associated with increased risk of RSV hospitalizationRSV hospitalization rates among different racial and ethnic minority groups and socioeconomic statuses Faculty:Angela Branche, MD, FIDSAAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicineUniversity of RochesterRochester, New YorkContent based on a CME p...2024-05-0714 minMedscape InDiscussion: Respiratory Syncytial Virus in AdultsEpidemiology of RSV: Accurate Diagnosis, Treatment Options, and Risk FactorsJoin Drs Forest Arnold and Angela R. Branche as they discuss the epidemiology of RSV, the importance of an accurate diagnosis, treatment options, cohorting, and risk factors. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/998283. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview Seasonality of Respiratory Syncytial Virus — United States, 2017–2023 https://www.cdc.gov/mmwr/volumes/72/wr/mm7214a1.h...2024-05-0221 min
Cocooned HealthEp 6. RSV Ready: New Mumma Vaccine and Antibody Breakthroughs. Expert Guest: Professor Paul HeathEpisode 6. RSV Ready: New Mumma Vaccine and Antibody Breakthroughs. Expert Guest: Professor Paul Heath
Paul Heath is a Professor and Honorary Consultant in Paediatric Infectious Diseases at St George's University Hospitals NHS Foundation Trust and St George’s, University of London, where he is the Director of the Vaccine Institute.
His research interests include the epidemiology of vaccine preventable diseases, and clinical vaccine trials, particularly in at-risk groups and in perinatal infections. He coordinates the UK Paediatric Vaccine Group (UKPVG), is a member of the JCVI, is the NIHR Speciality Lead for Children’s research for...2024-04-1532 min
The Skeptics Guide to Emergency MedicineSGEM #435: Don’t Stop Believing…A Vaccine can Work for RSVReference: Drysdale SB et al. Nirsevimab for Prevention of Hospitalizations due to RSV in Infants. N Engl J Med. 2023
Date: March 29, 2024
Guest Skeptic: Dr. Michael Cosimini is a pediatrician in Portland Oregon. He is the designer of Empiric Game, a medical editor and contributor to Pediatrics Reviews and Perspectives (PedsRAP) and the digital media editor at Academic Pediatrics. He is passionate about podcasting and serious games for medical education.
Dr. Michael Cosimini
Case: A 4-month-old twin girl is brought by her parents to the emergency department (ED) for respiratory distress. She has had congestion, a runny nose, and a cough f...2024-04-0627 minMedscape InDiscussion: Respiratory Syncytial Virus in AdultsRSV and Healthcare Facilities: Preventing Outbreaks and Minimizing Transmission With Education, Testing, and CohortingJoin Drs Forest Arnold and Hannah Nam as they discuss preventing RSV outbreaks within healthcare facilities, and strategies to minimize RSV transmission among healthcare workers and patients. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/998282). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET) https://www.cdc.gov/rsv/research/rsv-net/index...2024-04-0319 min
Respiratory ExchangeRSV Vaccination for Older AdultsWelcome to a special series by Respiratory Exchange Addressing the Impact of RSV and Vaccine Hesitancy. In this series, we explore the efficacy of RSV vaccines and discuss preventive strategies aimed at reducing the occurrence of severe RSV respiratory illness in infants, children and older adults. This episode will focus on the RSV Vaccination for Older Adults, and the importance of vaccination in preventing severe illness and hospitalization. Dr. Ronan Factora explains the risks and the benefits of the RSV vaccine while emphasizing the potential consequences of hospitalization including the loss of independence.2024-03-1326 min
POMA DOes...RSV and Influenza: Pediatric Patients and Pregnant MothersEpisode Summary: Despite a multiyear pandemic and availability of vaccines to decrease the impact of severe respiratory viral infections, such as RSV and Influenza, thousands of patients are hospitalized every year. Additionally, healthcare professionals and the general public have not achieved a satisfactory immunization rate for these infections. In today’s episode we sit down with a pediatrician and an obstetrician to discuss RSV and Influenza in pregnant and pediatric patients, the risks of severe infection, and available vaccines and treatment options. Key Takeaways: RSV and Influenza are common, highly contagious vir...2024-03-0822 min
Inside Family MedicineDr. LaTasha Seliby Perkins: A Maternal RSV Vaccination DiscussionHear from family physician LaTasha Seliby Perkins, MD, FAAFP, on maternal RSV vaccination guidelines and recommendations and ways to overcome vaccine hesitancy. Vaccines newly available in the 2023-2024 respiratory season are presenting new opportunities to protect against RSV, but vaccine hesitancy continues to present challenges in increasing vaccination rates for flu, COVID-19 and RSV. Dr. Seliby-Perkins outlines the responsibility of family doctors in educating their most vulnerable patients about these vaccines and clarifying any concerns among them and offers concrete tips for overcoming vaccine hesitancy. Learn more from the AAFP about vaccines for COVID-19 and...2024-03-0718 min
'ne Dosis Wissen | Der Medizin-Podcast für Menschen im GesundheitswesenSäuglinge seltener im Krankenhaus durch RSV-Prophylaxe
Jeden Winter landen viele Säuglinge in den Krankenhäusern auf Grund einer RSV-Infektion. Dabei müsste das nicht sein: Eine passive Immunisierung mit einem neuen Antikörper scheint auch unter realen Bedingungen die Zahl der Krankenhausaufenthalte deutlich zu reduzieren. Dr. Laura Weisenburger, Ärztin und Redakteurin bei der Apotheken Umschau, stellt eine Studie aus Luxemburg vor.
Stand: 16. Februar 2024
Quellen und nützliche Links:
Aktuelle Studie zur Wirkung einer RSV-Prophylaxe im klinischen Alltag (engl.)
Europäische Arzneimittel-Agentur. Zulassungsempfehlung für Nirsevimab (engl.)
Klinische Studie zur Wirksamkeit von Nirsevimab als RSV-Prophylaxe (engl.)
Studie zur Krankheitslast von RSV-Infe...2024-02-1608 minPOMA DOes...RSV and Influenza: Older Adults and Immunocompromised PatientsEpisode Summary: Despite a multiyear pandemic and availability of vaccines to decrease the impact of severe respiratory viral infections, such as RSV and Influenza, thousands of patients are hospitalized every year. Additionally, healthcare professionals and the general public have not achieved a satisfactory immunization rate for these infections. In today’s episode we sit down with a pulmonologist and a hospitalist to discuss RSV and Influenza, at-risk patient populations, the risks of severe infection, and available vaccines and treatment options. Key Takeaways: The CDC estimates there have been at least 20 million ill...2024-02-0951 minMedscape InDiscussion: Respiratory Syncytial Virus in AdultsRisk Factors and Complications of RSV in AdultsJoin Drs Forest Arnold and Edward Walsh as they discuss risk factors and complications of RSV in adults. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/998278). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources RSV Surveillance & Research https://www.cdc.gov/rsv/research/index.html Respiratory Viral Infections in the Elderly https://pubmed.ncbi.nlm.nih.gov/33749408/ Structure and Function of Respiratory Syncytial Virus Surface Glycoproteins...2024-02-0118 min
PaidiatrosmouRSV ιόςΓεια σας και καλωσηρθατε στο δεύτερο επεισόδιο του ποντκαστ Paidiatrosmou. Είμαι ο Στράτος και σήμερα θα μιλήσουμε για τον RSV ή αλλιώς αναπνευστικό συγκυτιακό ιό. Συγκεκριμένα θα απαντήσουμε στα ερωτήματα: Τι προκαλεί αυτός ο ιος και ποια τα χαρακτηριστικά του; Ποια παιδάκια κινδυνεύουν περισσότερο; Ποια είναι τα συμπτώματα και ποια η θεραπεία και πολλά άλλα.
Περιεχόμενο:
0:55 Τι είναι ο RSV ιός;
1:25 Ποια τα συμπτώματα;
03:35 Γιατί τους τελευταίους 2 χειμώνες παρατηρήσαμε τόσα πολλά και σοβαρά κρούσματα;
04:53 Περνάνε όλα τα παιδιά τον RSV;
05:55 Ποια τα χαρακτηριστικά του RSV ιού;
06:30 Πώς μεταδίδεται ο ιός;
07:58 Γίνεται να περάσουμε τον ιό πάνω από μια φορά;
08:48 Πότε εμφανίζονται τα πρώτα συμπτώματα;
10:05 Πώς θα καταλάβετε αν το παιδί έχει προσβληθεί από RSV;
11:00 Ποια παιδιά κινδυνεύουν περισσότερο;
11:42 Τι πρέπει να προσέχετε στο σπίτι;
14:28 Ποια η θεραπεία;
17:20 Σύνοψη θεραπείας.
18:10 Υπάρχουν μακροχρόνιες επιπτώσεις μετά από λοίμωξη με RSV ιό;
20:04 Μέτρα πρόληψης.
22:08 Σύνοψη και take home messages.
2024-01-1723 min
Conversations with CEIRSV Vaccination in HIV Positive AdultsRSV vaccine for adults has recently become available and can protect against severe disease or death from one of the main causes of upper respiratory infections. HIV patients are asking if they should receive the vaccine. This question is discussed by Dr. Steven Fine. Related Content:
Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting: DOI: https://doi.org/10.1016/j.jinf.2017.06.007
Immunizations for Adults with HIV: https://www.hivguidelines.org/guideline/hiv-immunizations/?mycollection=hiv-care.
CDC: Respiratory Syncytial Virus (RSV) Vaccine VIS: https://www.cdc.gov/vaccines/hcp/vis/vis-statements/rsv.html#:~...2024-01-1111 min
CCO Infectious Disease PodcastRSV Vaccines in Adults: A Risk-Based ApproachIn this episode, Angela Branche, MD, discusses RSV vaccines in older adults, including: Current Advisory Committee on Immunization Practices recommendationsRisk factors associated with severe RSV disease, including RSV-related hospitalizationsApproach to stratifying risk factors (eg, age, comorbidities) in determining which adults may benefit from the RSV vaccine Ongoing research on RSV vaccines in younger adults (eg, aged 40s and 50s years) with chronic comorbidities Health disparities related to RSV vaccinesConsiderations for a risk-based approach, rather than age alone, to determine vaccine candidacy Faculty: Angela Branche, MDAssociate Professor of MedicineDivision of Infectious Diseases...2023-12-2709 minVerifiedRxRollout Strategy Vexing: Pediatric RSV prevention strategy implementation challengesRSV infections are not new and have devastating impacts. The recent advent of new prevention strategies has renewed the focus on the disease with a hopeful outlook. For the last 25 years, the only FDA approved product preventing RSV, lower respiratory tract disease, was palivizumab or Synagis, a monoclonal antibody indicated for use in high risk infants children and administered intramuscularly monthly throughout the RSV season.
In May, the first ever RSV vaccines were approved, Arexvy and Abrysvo. These two new RSV vaccines were approved for use in adults greater than or equal to 60 years of age. In...2023-12-2625 min
We Talk Health - Official Podcast of West Tennessee Healthcare174. RSV During the Holiday SeasonOn this episode of We Talk Health, Dr. Pela shares all about the spread of RSV during the holiday season.Many people are planning get-togethers and family gatherings for the holidays, but it's also flu season, and during this time, viruses such as RSV are going around as well. We discuss what the symptoms of RSV look like in infants and children, how to prevent the spread and what to do if your baby gets RSV.Guest:Tarebiye Pela, MDPediatrician, West Tennessee Medical GroupHost:...2023-12-1508 min